- Home
- AKYA vs TLSA Comparison
AKYA vs TLSA Comparison
Compare AKYA & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKYA
- TLSA
- Stock Information
- Founded
- AKYA 2015
- TLSA 2013
- Country
- AKYA United States
- TLSA United Kingdom
- Employees
- AKYA N/A
- TLSA N/A
- Industry
- AKYA Medical Specialities
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- AKYA Industrials
- TLSA Health Care
- Exchange
- AKYA Nasdaq
- TLSA Nasdaq
- Market Cap
- AKYA 84.7M
- TLSA 87.8M
- IPO Year
- AKYA 2021
- TLSA 2000
- Fundamental
- Price
- AKYA $1.35
- TLSA $1.06
- Analyst Decision
- AKYA Buy
- TLSA
- Analyst Count
- AKYA 7
- TLSA 0
- Target Price
- AKYA $3.26
- TLSA N/A
- AVG Volume (30 Days)
- AKYA 251.7K
- TLSA 925.9K
- Earning Date
- AKYA 05-12-2025
- TLSA 05-09-2025
- Dividend Yield
- AKYA N/A
- TLSA N/A
- EPS Growth
- AKYA N/A
- TLSA N/A
- EPS
- AKYA N/A
- TLSA N/A
- Revenue
- AKYA $81,672,000.00
- TLSA N/A
- Revenue This Year
- AKYA $13.94
- TLSA N/A
- Revenue Next Year
- AKYA $14.48
- TLSA N/A
- P/E Ratio
- AKYA N/A
- TLSA N/A
- Revenue Growth
- AKYA N/A
- TLSA N/A
- 52 Week Low
- AKYA $1.32
- TLSA $0.41
- 52 Week High
- AKYA $4.65
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- AKYA 29.49
- TLSA 43.53
- Support Level
- AKYA $1.32
- TLSA $1.01
- Resistance Level
- AKYA $1.78
- TLSA $1.30
- Average True Range (ATR)
- AKYA 0.14
- TLSA 0.16
- MACD
- AKYA 0.01
- TLSA -0.06
- Stochastic Oscillator
- AKYA 6.52
- TLSA 14.71
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.